[Peritoneal dissemination of ovarian cancer and tumor angiogenesis]

Nihon Rinsho. 2004 Oct:62 Suppl 10:467-70.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antimetabolites, Antineoplastic / therapeutic use
  • Bevacizumab
  • Capecitabine
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Female
  • Fluorouracil / analogs & derivatives
  • Humans
  • Neovascularization, Pathologic / genetics*
  • Ovarian Neoplasms / blood supply*
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / pathology*
  • Peritoneal Neoplasms / blood supply*
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / pathology
  • Peritoneal Neoplasms / secondary*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / physiology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antimetabolites, Antineoplastic
  • Vascular Endothelial Growth Factor A
  • Deoxycytidine
  • Bevacizumab
  • Capecitabine
  • Fluorouracil